Gene Editing Co. Bluebird Bio Offers 3.4M Shares At $162
Bluebird Bio Inc. put up for sale nearly 3.4 million more shares of common stock this week at $162.50 per share in a public offering from the longtime member of the bio-pharma hub in ...To view the full article, register now.
Already a subscriber? Click here to view full article